Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1.
Recent meta-analyses of schizophrenia genome-wide association studies (GWASs) have identified the CUB and SUSHI multiple domains 1 (CSMD1) gene as a statistically strong risk factor. CSMD1 is a complement control-related protein suggested to inhibit the classical complement pathway, being expressed...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d88e54d129544816924ae23e36500782 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d88e54d129544816924ae23e36500782 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d88e54d129544816924ae23e365007822021-11-18T08:46:30ZNeuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1.1932-620310.1371/journal.pone.0079501https://doaj.org/article/d88e54d129544816924ae23e365007822013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24244513/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Recent meta-analyses of schizophrenia genome-wide association studies (GWASs) have identified the CUB and SUSHI multiple domains 1 (CSMD1) gene as a statistically strong risk factor. CSMD1 is a complement control-related protein suggested to inhibit the classical complement pathway, being expressed in developing neurons. However, expression of CSMD1 is largely uncharacterized and relevance for behavioral phenotypes is not previously demonstrated. Here, we assess neuropsychological behaviors of a Csmd1 knockout (KO) mouse in a selection of standard behavioral tests. Deregulation of neuropsychological responses were observed in both the open field and the elevated plus maze tests, in which KO mice spent 55% and 33% less time than WT littermate mice in open areas, respectively. Altered behaviors were also observed in tail suspension and to higher acoustic stimuli, for which Csmd1 KO mice showed helplessness and moderate increase in startle amplitude, respectively. Furthermore, Csmd1 KO mice also displayed increased weight-gain and glucose tolerance, similar to a major phenotype of the metabolic syndrome that also has been associated to the human CSMD1 locus. Consistent with a role in the control of behaviors, Csmd1 was found highly expressed in the central nervous system (CNS), and with some expression in visceral fat and ovary, under tissue-specific control by a novel promoter-associated lncRNA. In summary, disruption of Csmd1 induces behaviors reminiscent of blunted emotional responses, anxiety and depression. These observations suggest an influence of the CSMD1 schizophrenia susceptibility gene on psychopathology and endophenotypes of the negative symptom spectra.Vidar M SteenChirag NepalKari M ErslandRita HoldhusMarianne NævdalSiri M RatvikSilje SkredeBjarte HåvikPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e79501 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Vidar M Steen Chirag Nepal Kari M Ersland Rita Holdhus Marianne Nævdal Siri M Ratvik Silje Skrede Bjarte Håvik Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. |
description |
Recent meta-analyses of schizophrenia genome-wide association studies (GWASs) have identified the CUB and SUSHI multiple domains 1 (CSMD1) gene as a statistically strong risk factor. CSMD1 is a complement control-related protein suggested to inhibit the classical complement pathway, being expressed in developing neurons. However, expression of CSMD1 is largely uncharacterized and relevance for behavioral phenotypes is not previously demonstrated. Here, we assess neuropsychological behaviors of a Csmd1 knockout (KO) mouse in a selection of standard behavioral tests. Deregulation of neuropsychological responses were observed in both the open field and the elevated plus maze tests, in which KO mice spent 55% and 33% less time than WT littermate mice in open areas, respectively. Altered behaviors were also observed in tail suspension and to higher acoustic stimuli, for which Csmd1 KO mice showed helplessness and moderate increase in startle amplitude, respectively. Furthermore, Csmd1 KO mice also displayed increased weight-gain and glucose tolerance, similar to a major phenotype of the metabolic syndrome that also has been associated to the human CSMD1 locus. Consistent with a role in the control of behaviors, Csmd1 was found highly expressed in the central nervous system (CNS), and with some expression in visceral fat and ovary, under tissue-specific control by a novel promoter-associated lncRNA. In summary, disruption of Csmd1 induces behaviors reminiscent of blunted emotional responses, anxiety and depression. These observations suggest an influence of the CSMD1 schizophrenia susceptibility gene on psychopathology and endophenotypes of the negative symptom spectra. |
format |
article |
author |
Vidar M Steen Chirag Nepal Kari M Ersland Rita Holdhus Marianne Nævdal Siri M Ratvik Silje Skrede Bjarte Håvik |
author_facet |
Vidar M Steen Chirag Nepal Kari M Ersland Rita Holdhus Marianne Nævdal Siri M Ratvik Silje Skrede Bjarte Håvik |
author_sort |
Vidar M Steen |
title |
Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. |
title_short |
Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. |
title_full |
Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. |
title_fullStr |
Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. |
title_full_unstemmed |
Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. |
title_sort |
neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene csmd1. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/d88e54d129544816924ae23e36500782 |
work_keys_str_mv |
AT vidarmsteen neuropsychologicaldeficitsinmicedepletedoftheschizophreniasusceptibilitygenecsmd1 AT chiragnepal neuropsychologicaldeficitsinmicedepletedoftheschizophreniasusceptibilitygenecsmd1 AT karimersland neuropsychologicaldeficitsinmicedepletedoftheschizophreniasusceptibilitygenecsmd1 AT ritaholdhus neuropsychologicaldeficitsinmicedepletedoftheschizophreniasusceptibilitygenecsmd1 AT mariannenævdal neuropsychologicaldeficitsinmicedepletedoftheschizophreniasusceptibilitygenecsmd1 AT sirimratvik neuropsychologicaldeficitsinmicedepletedoftheschizophreniasusceptibilitygenecsmd1 AT siljeskrede neuropsychologicaldeficitsinmicedepletedoftheschizophreniasusceptibilitygenecsmd1 AT bjartehavik neuropsychologicaldeficitsinmicedepletedoftheschizophreniasusceptibilitygenecsmd1 |
_version_ |
1718421352990375936 |